Search

Search Constraints

You searched for: Author/Creator Gennigens, Christine

Search Results

1. 2022-RA-1392-ESGO Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: interim results of ENGOT Cx8/GOG-3024/innovaTV205. (20th October 2022)

2. 2022-RA-193-ESGO Cost-effectiveness of molecular profiling for endometrial neoplasia: a single institution experience. (20th October 2022)

3. 2022-RA-438-ESGO A comparison of survival and recurrence pattern of patients presenting locally advanced cervical cancer according to the histological subtype: a monocentric retrospective study. (20th October 2022)

4. 2022-RA-955-ESGO Endometrial cancer: lymphovascular space invasion is a negative prognostic factor. (20th October 2022)

5. 2022-RA-967-ESGO Endometrial cancer: agreement between microsatellite instability in immunohistochemistry and molecular biology?. (20th October 2022)

6. Added value of para-aortic surgical staging compared to 18F-FDG PET/CT on the external beam radiation field for patients with locally advanced cervical cancer: An ONCO-GF study. Issue 5 (May 2020)

7. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience. (21st October 2015)

8. Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy. (20th September 2020)

9. Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study. Issue 5 (May 2021)

10. EP150/#325 Endometrial cancer: agreement between P53 immunohistochemistry and TP53 mutational analysis?. (4th December 2022)